MersV1, Ncbi, Merge, bibRecord, 000244

Development of immunoglobulin variable heavy chain gene consensus probes with conjugated 3' minor groove binder groups for monitoring minimal residual disease in childhood acute lymphoblastic leukaemia.

Identifieur interne : 000244 ( Ncbi/Merge ); précédent : 000243; suivant : 000245

Development of immunoglobulin variable heavy chain gene consensus probes with conjugated 3' minor groove binder groups for monitoring minimal residual disease in childhood acute lymphoblastic leukaemia.

Auteurs : M. Uchiyama [Japon] ; C. Maesawa ; A. Yashima ; T. Itabashi ; T. Satoh ; M. Tarusawa ; M. Endo ; Y. Takahashi ; S. Sasaki ; S. Tsuchiya ; Y. Ishida ; T. Masuda

Source :

Journal of clinical pathology [ 0021-9746 ] ; 2003.

RBID : pubmed:14645357

Descripteurs français

English descriptors

KwdEn :
- Child, Consensus Sequence (genetics), Gene Rearrangement, B-Lymphocyte, Heavy Chain, Humans, Immunoglobulin Heavy Chains (genetics), Immunoglobulin Variable Region (genetics), Neoplasm, Residual, Oligonucleotide Probes, Polymerase Chain Reaction (methods), Precursor Cell Lymphoblastic Leukemia-Lymphoma (diagnosis), Sequence Alignment.
MESH :
- chemical , genetics : Immunoglobulin Heavy Chains, Immunoglobulin Variable Region.
- diagnosis : Precursor Cell Lymphoblastic Leukemia-Lymphoma.
- genetics : Consensus Sequence.
- methods : Polymerase Chain Reaction.
- Child, Gene Rearrangement, B-Lymphocyte, Heavy Chain, Humans, Neoplasm, Residual, Oligonucleotide Probes, Sequence Alignment.

Abstract

To develop immunoglobulin heavy chain variable (VH) gene probes that are shorter and more flexible in position for monitoring minimal residual disease (MRD) in childhood leukaemia (ALL), using minor groove binder (MGB) technology.

DOI: 10.1136/jcp.56.12.952
PubMed: 14645357

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 002425
to stream PubMed, to step Curation: 002425
to stream PubMed, to step Checkpoint: 002328

Links to Exploration step

pubmed:14645357

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development of immunoglobulin variable heavy chain gene consensus probes with conjugated 3' minor groove binder groups for monitoring minimal residual disease in childhood acute lymphoblastic leukaemia.</title>
<author><name sortKey="Uchiyama, M" sort="Uchiyama, M" uniqKey="Uchiyama M" first="M" last="Uchiyama">M. Uchiyama</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, Iwate Medical University School of Medicine, Uchimaru 19-1, Morioka 020-8505, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Pathology, Iwate Medical University School of Medicine, Uchimaru 19-1, Morioka 020-8505</wicri:regionArea>
<wicri:noRegion>Morioka 020-8505</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Maesawa, C" sort="Maesawa, C" uniqKey="Maesawa C" first="C" last="Maesawa">C. Maesawa</name>
</author>
<author><name sortKey="Yashima, A" sort="Yashima, A" uniqKey="Yashima A" first="A" last="Yashima">A. Yashima</name>
</author>
<author><name sortKey="Itabashi, T" sort="Itabashi, T" uniqKey="Itabashi T" first="T" last="Itabashi">T. Itabashi</name>
</author>
<author><name sortKey="Satoh, T" sort="Satoh, T" uniqKey="Satoh T" first="T" last="Satoh">T. Satoh</name>
</author>
<author><name sortKey="Tarusawa, M" sort="Tarusawa, M" uniqKey="Tarusawa M" first="M" last="Tarusawa">M. Tarusawa</name>
</author>
<author><name sortKey="Endo, M" sort="Endo, M" uniqKey="Endo M" first="M" last="Endo">M. Endo</name>
</author>
<author><name sortKey="Takahashi, Y" sort="Takahashi, Y" uniqKey="Takahashi Y" first="Y" last="Takahashi">Y. Takahashi</name>
</author>
<author><name sortKey="Sasaki, S" sort="Sasaki, S" uniqKey="Sasaki S" first="S" last="Sasaki">S. Sasaki</name>
</author>
<author><name sortKey="Tsuchiya, S" sort="Tsuchiya, S" uniqKey="Tsuchiya S" first="S" last="Tsuchiya">S. Tsuchiya</name>
</author>
<author><name sortKey="Ishida, Y" sort="Ishida, Y" uniqKey="Ishida Y" first="Y" last="Ishida">Y. Ishida</name>
</author>
<author><name sortKey="Masuda, T" sort="Masuda, T" uniqKey="Masuda T" first="T" last="Masuda">T. Masuda</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:14645357</idno>
<idno type="pmid">14645357</idno>
<idno type="doi">10.1136/jcp.56.12.952</idno>
<idno type="wicri:Area/PubMed/Corpus">002425</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002425</idno>
<idno type="wicri:Area/PubMed/Curation">002425</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002425</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002328</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002328</idno>
<idno type="wicri:Area/Ncbi/Merge">000244</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Development of immunoglobulin variable heavy chain gene consensus probes with conjugated 3' minor groove binder groups for monitoring minimal residual disease in childhood acute lymphoblastic leukaemia.</title>
<author><name sortKey="Uchiyama, M" sort="Uchiyama, M" uniqKey="Uchiyama M" first="M" last="Uchiyama">M. Uchiyama</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Pathology, Iwate Medical University School of Medicine, Uchimaru 19-1, Morioka 020-8505, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Pathology, Iwate Medical University School of Medicine, Uchimaru 19-1, Morioka 020-8505</wicri:regionArea>
<wicri:noRegion>Morioka 020-8505</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Maesawa, C" sort="Maesawa, C" uniqKey="Maesawa C" first="C" last="Maesawa">C. Maesawa</name>
</author>
<author><name sortKey="Yashima, A" sort="Yashima, A" uniqKey="Yashima A" first="A" last="Yashima">A. Yashima</name>
</author>
<author><name sortKey="Itabashi, T" sort="Itabashi, T" uniqKey="Itabashi T" first="T" last="Itabashi">T. Itabashi</name>
</author>
<author><name sortKey="Satoh, T" sort="Satoh, T" uniqKey="Satoh T" first="T" last="Satoh">T. Satoh</name>
</author>
<author><name sortKey="Tarusawa, M" sort="Tarusawa, M" uniqKey="Tarusawa M" first="M" last="Tarusawa">M. Tarusawa</name>
</author>
<author><name sortKey="Endo, M" sort="Endo, M" uniqKey="Endo M" first="M" last="Endo">M. Endo</name>
</author>
<author><name sortKey="Takahashi, Y" sort="Takahashi, Y" uniqKey="Takahashi Y" first="Y" last="Takahashi">Y. Takahashi</name>
</author>
<author><name sortKey="Sasaki, S" sort="Sasaki, S" uniqKey="Sasaki S" first="S" last="Sasaki">S. Sasaki</name>
</author>
<author><name sortKey="Tsuchiya, S" sort="Tsuchiya, S" uniqKey="Tsuchiya S" first="S" last="Tsuchiya">S. Tsuchiya</name>
</author>
<author><name sortKey="Ishida, Y" sort="Ishida, Y" uniqKey="Ishida Y" first="Y" last="Ishida">Y. Ishida</name>
</author>
<author><name sortKey="Masuda, T" sort="Masuda, T" uniqKey="Masuda T" first="T" last="Masuda">T. Masuda</name>
</author>
</analytic>
<series><title level="j">Journal of clinical pathology</title>
<idno type="ISSN">0021-9746</idno>
<imprint><date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Child</term>
<term>Consensus Sequence (genetics)</term>
<term>Gene Rearrangement, B-Lymphocyte, Heavy Chain</term>
<term>Humans</term>
<term>Immunoglobulin Heavy Chains (genetics)</term>
<term>Immunoglobulin Variable Region (genetics)</term>
<term>Neoplasm, Residual</term>
<term>Oligonucleotide Probes</term>
<term>Polymerase Chain Reaction (methods)</term>
<term>Precursor Cell Lymphoblastic Leukemia-Lymphoma (diagnosis)</term>
<term>Sequence Alignment</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Alignement de séquences</term>
<term>Chaines lourdes des immunoglobulines (génétique)</term>
<term>Enfant</term>
<term>Humains</term>
<term>Leucémie-lymphome lymphoblastique à précurseurs B et T (diagnostic)</term>
<term>Maladie résiduelle</term>
<term>Réaction de polymérisation en chaîne ()</term>
<term>Réarrangement des gènes des chaines lourdes des lymphocytes B</term>
<term>Région variable d'immunoglobuline (génétique)</term>
<term>Sondes oligonucléotidiques</term>
<term>Séquence consensus (génétique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Immunoglobulin Heavy Chains</term>
<term>Immunoglobulin Variable Region</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Leucémie-lymphome lymphoblastique à précurseurs B et T</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Consensus Sequence</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Chaines lourdes des immunoglobulines</term>
<term>Région variable d'immunoglobuline</term>
<term>Séquence consensus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Polymerase Chain Reaction</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Child</term>
<term>Gene Rearrangement, B-Lymphocyte, Heavy Chain</term>
<term>Humans</term>
<term>Neoplasm, Residual</term>
<term>Oligonucleotide Probes</term>
<term>Sequence Alignment</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Alignement de séquences</term>
<term>Enfant</term>
<term>Humains</term>
<term>Maladie résiduelle</term>
<term>Réaction de polymérisation en chaîne</term>
<term>Réarrangement des gènes des chaines lourdes des lymphocytes B</term>
<term>Sondes oligonucléotidiques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To develop immunoglobulin heavy chain variable (VH) gene probes that are shorter and more flexible in position for monitoring minimal residual disease (MRD) in childhood leukaemia (ALL), using minor groove binder (MGB) technology.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">14645357</PMID>
<DateCompleted><Year>2004</Year>
<Month>01</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>05</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0021-9746</ISSN>
<JournalIssue CitedMedium="Print"><Volume>56</Volume>
<Issue>12</Issue>
<PubDate><Year>2003</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of clinical pathology</Title>
<ISOAbbreviation>J. Clin. Pathol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Development of immunoglobulin variable heavy chain gene consensus probes with conjugated 3' minor groove binder groups for monitoring minimal residual disease in childhood acute lymphoblastic leukaemia.</ArticleTitle>
<Pagination><MedlinePgn>952-5</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To develop immunoglobulin heavy chain variable (VH) gene probes that are shorter and more flexible in position for monitoring minimal residual disease (MRD) in childhood leukaemia (ALL), using minor groove binder (MGB) technology.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">All VH germline sequences registered in the database were aligned and the consensus regions were determined. The reliability of the MGB probes was compared with non-MGB probes in all 24 cases of ALL.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Ten MGB probes (16 to 18 mers) were designed that enabled all the germline sequences on the database to be analysed, whereas the conventional non-MGB probes (21 to 27 mers) did not allow the analysis of four of the VH1 and five of the VH3 germline sequences. The sequencing results in five of the 24 cases of ALL were not matched to the non-MGB probes.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">MGB technology allows shorter probes to be designed, enabling MRD to be detected in childhood ALL. This would provide a considerable reduction in cost for a large MRD study.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Uchiyama</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Pathology, Iwate Medical University School of Medicine, Uchimaru 19-1, Morioka 020-8505, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Maesawa</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Yashima</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Itabashi</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Satoh</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tarusawa</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Endo</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Takahashi</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sasaki</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tsuchiya</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ishida</LastName>
<ForeName>Y</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Masuda</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>J Clin Pathol</MedlineTA>
<NlmUniqueID>0376601</NlmUniqueID>
<ISSNLinking>0021-9746</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007143">Immunoglobulin Heavy Chains</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007135">Immunoglobulin Variable Region</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015345">Oligonucleotide Probes</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016384" MajorTopicYN="N">Consensus Sequence</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015326" MajorTopicYN="N">Gene Rearrangement, B-Lymphocyte, Heavy Chain</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007143" MajorTopicYN="N">Immunoglobulin Heavy Chains</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007135" MajorTopicYN="N">Immunoglobulin Variable Region</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018365" MajorTopicYN="N">Neoplasm, Residual</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015345" MajorTopicYN="Y">Oligonucleotide Probes</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054198" MajorTopicYN="N">Precursor Cell Lymphoblastic Leukemia-Lymphoma</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016415" MajorTopicYN="N">Sequence Alignment</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2004</Year>
<Month>1</Month>
<Day>27</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2003</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">14645357</ArticleId>
<ArticleId IdType="pmc">PMC1770149</ArticleId>
<ArticleId IdType="doi">10.1136/jcp.56.12.952</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Mod Pathol. 2000 Dec;13(12):1269-79</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11144922</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Hematol. 2002 Feb;75(2):166-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11939263</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Pathol. 1992 Sep;45(9):770-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1401205</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2000 Jan 15;28(2):655-61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10606668</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Blood. 2000 Apr 15;95(8):2651-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10753847</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Leukemia. 2000 Aug;14(8):1419-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10942238</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Leukemia. 2000 Aug;14(8):1426-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10942239</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Exp Hematol. 2000 Sep;28(9):1039-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11008016</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Japon</li>
</country>
</list>
<tree><noCountry><name sortKey="Endo, M" sort="Endo, M" uniqKey="Endo M" first="M" last="Endo">M. Endo</name>
<name sortKey="Ishida, Y" sort="Ishida, Y" uniqKey="Ishida Y" first="Y" last="Ishida">Y. Ishida</name>
<name sortKey="Itabashi, T" sort="Itabashi, T" uniqKey="Itabashi T" first="T" last="Itabashi">T. Itabashi</name>
<name sortKey="Maesawa, C" sort="Maesawa, C" uniqKey="Maesawa C" first="C" last="Maesawa">C. Maesawa</name>
<name sortKey="Masuda, T" sort="Masuda, T" uniqKey="Masuda T" first="T" last="Masuda">T. Masuda</name>
<name sortKey="Sasaki, S" sort="Sasaki, S" uniqKey="Sasaki S" first="S" last="Sasaki">S. Sasaki</name>
<name sortKey="Satoh, T" sort="Satoh, T" uniqKey="Satoh T" first="T" last="Satoh">T. Satoh</name>
<name sortKey="Takahashi, Y" sort="Takahashi, Y" uniqKey="Takahashi Y" first="Y" last="Takahashi">Y. Takahashi</name>
<name sortKey="Tarusawa, M" sort="Tarusawa, M" uniqKey="Tarusawa M" first="M" last="Tarusawa">M. Tarusawa</name>
<name sortKey="Tsuchiya, S" sort="Tsuchiya, S" uniqKey="Tsuchiya S" first="S" last="Tsuchiya">S. Tsuchiya</name>
<name sortKey="Yashima, A" sort="Yashima, A" uniqKey="Yashima A" first="A" last="Yashima">A. Yashima</name>
</noCountry>
<country name="Japon"><noRegion><name sortKey="Uchiyama, M" sort="Uchiyama, M" uniqKey="Uchiyama M" first="M" last="Uchiyama">M. Uchiyama</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000244 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000244 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:14645357
   |texte=   Development of immunoglobulin variable heavy chain gene consensus probes with conjugated 3' minor groove binder groups for monitoring minimal residual disease in childhood acute lymphoblastic leukaemia.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:14645357" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021

	Serveur d'exploration MERS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration MERS

Development of immunoglobulin variable heavy chain gene consensus probes with conjugated 3' minor groove binder groups for monitoring minimal residual disease in childhood acute lymphoblastic leukaemia.

Development of immunoglobulin variable heavy chain gene consensus probes with conjugated 3' minor groove binder groups for monitoring minimal residual disease in childhood acute lymphoblastic leukaemia.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki